AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Sexually Transmitted Diseases Diagnostics Market Insights, Competitive Landscape and, Market Forecast - 2027
... AND OTHERS), BY TESTING (LABORATORY DEVICES [PCR, LTERAL FLOW READERS IMMUNOCHROMATOGRAPHIC ASSAY, FLOW CYTOMETERS, ABSORBANCE MICROPLATE READERS ENZYME LINKED IMMUNOSORBENT ASSAY, AND OTHERS] AND POINT OF CARE DEVICES [PHONE CHIPS, PORTABLE/BENCH, AND DIAGNOSTIC KITS]), BY ... Read More
-
Genital Herpes - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... exports due to facility closures during the COVID-19 pandemic had a short-term adverse impact on the market's growth in the pandemic's preliminary phase due to supply chain disruptions and the unavailability of human resources. However, ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline landscape. Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Oral ... Read More
-
Infectious Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... USD 50,345.74 million. The infectious disease diagositcs market is expected to register a CAGR of 3.79% over the forecast period (2022-2027). The market for infectious illness diagnostics has been considerably affected by the COVID-19 epidemic. ... Read More
-
Cell Counting Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... significant impact on the adoption of cell counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia are the potential indicators of COVID-19. The study published in BMC ... Read More
-
HIV/AIDS Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... dramatic decline in HIV testing and, as a consequence, a much lower number of new HIV diagnoses. In May 2022, an article published titled "COVID Caused Drop-in HIV Testing, Diagnoses" stated that the Centers for ... Read More
-
Global Warts Therapeutics Market - 2022-2029
... during the forecast period (2022-2029). Warts are skin growth that is caused by the human papillomavirus (HPV). It may persist for years and recurs at the same or different sites, even after treatment. Some factors ... Read More
-
Global self-testing kits market trends and forecasts
... estimates from 2022, and projections of compound annual growth rates (CAGRs) through 2027 (forecast period 2022–2027) and examines regional markets for self-testing kits. This report will highlight the current and future market potential of self-testing ... Read More
-
Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... Virus Treatment Market Growth & Trends The global herpes simplex virus treatment market size is expected to reach USD 3.75 billion by 2030, according to a new report by Grand View Research, Inc., expanding at ... Read More
-
HIV Diagnostics Market
... 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision. ... Read More
-
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region
... Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region The global pulse oximeter market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 2.6 ... Read More
-
Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and ... Read More
-
Middle East and Africa Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The MEA Anti-infective agents market was valued at US$ 8,188.65 million in ... Read More
-
Asia Pacific Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The APAC anti-infective agents market was valued at US$ 35,281.27 million in 2022 and ... Read More
-
The 2022 World Market for Vaccines
... some of the deadliest dis eases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in 2022. Compare this to just $25 billion in 2010. Since the ... Read More
-
Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Gonorrhea Clinical trials scenario. This report provides top line data relating to the clinical trials on Gonorrhea. Report includes ... Read More
-
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative ... Read More
-
Asia Pacific HIV Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening {Third Generation and Fourth Generation}, Differentiation & Confirmation Test, and Monitoring Test {CD4 Tests and Viral Load Tests}), by End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and Region
... & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and ... Read More
-
STD Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2026, registering a CAGR of nearly 8.7% during the forecast period, 2022-2027. The COVID-19 pandemic is expected to have a significant impact on sexually transmitted disease diagnostics. According to the Quest Diagnostics 2020 Health Trends, ... Read More
-
Genital Herpes Treatment Market - Global Outlook and Forecast 2022-2027
... is a widespread infection worldwide. HSV-1 causes infection in or around the mouth (oral herpes), but it can also cause genital herpes. Herpes simplex virus type 2 (HSV-2) causes genital herpes, a dangerous sexually transmitted ... Read More
-
Women's Health Diagnostics Market Analysis and Forecast till 2031: By Type (Diagnostic Devices, Diagnostic Tests, Accessories and Consumables), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing), End-use (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare) and Region
... (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare) and Region The global women's health diagnostics market was valued at USD 24.8 billion in 2021 and it is anticipated to grow up to USD 49.0 billion ... Read More
-
Drug Discovery Services Market Report 2022-2032
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Prevalence of Chronic Diseases to Boost Market ... Read More
Research Assistance
